Bioretec creates fully absorbable orthopedic implants—such as screws, plates, and fixation devices—that retain mechanical strength during bone healing and then safely dissolve, eliminating the need for hardware removal surgeries. Their bio‑resorbable materials are engineered to match bone remodeling timelines, reducing infection risk, postoperative discomfort, and overall treatment costs while integrating with standard surgical techniques.
Funding
$10.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Orthopedic surgeries often rely on permanent metal implants that require a second operation for removal, increasing patient risk, recovery time, and overall healthcare costs. Additionally, traditional implants can impede natural bone healing and may cause long-term complications.
Solution
Bioretec develops fully absorbable orthopedic implants designed to support bone healing and then safely dissolve, eliminating the need for hardware removal surgeries. Their product lines, such as Activa and RemeOs, use bio‑resorbable materials that maintain mechanical strength during the critical healing phase before being metabolized by the body. By integrating advanced polymer technology, the implants promote natural bone regeneration while reducing infection risk and postoperative discomfort. The company provides a portfolio of screws, plates, and other fixation devices that can be used across a range of fracture and joint reconstruction procedures, offering surgeons a seamless alternative to conventional metal hardware.
Target Audience
Primary customers are orthopedic surgeons and hospital orthopedic departments seeking implant solutions that reduce secondary procedures and improve patient outcomes.
Features
- Fully bio‑resorbable screws, plates, and fixation devices that retain strength during healing and then safely dissolve
- Materials engineered to match bone remodeling timelines, supporting natural osteogenesis
- Elimination of planned hardware removal surgeries, reducing patient morbidity and overall treatment costs
- Compatibility with standard orthopedic surgical techniques and instrumentation
- Regulatory approvals for use in major markets, including CMS pass‑through payment status in the United States